Yahoo Web Search

Search results

    • GSK Shares Plunge After Delaware Ruling on Zantac

      Morningstar· 3 hours ago

      By Helena Smolak GSK shares plummeted after a state court in Delaware on Friday found legitimate evidence that links its Zantac heartburn drug to cancer, allowing jury trials for these cases. At 0758 GMT, shares of GSK traded 9.3% lower